GB202108608D0 - Preparation of a ph-adjusted ascorbic acid solution - Google Patents
Preparation of a ph-adjusted ascorbic acid solutionInfo
- Publication number
- GB202108608D0 GB202108608D0 GBGB2108608.7A GB202108608A GB202108608D0 GB 202108608 D0 GB202108608 D0 GB 202108608D0 GB 202108608 A GB202108608 A GB 202108608A GB 202108608 D0 GB202108608 D0 GB 202108608D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- preparation
- adjusted
- acid solution
- ascorbic acid
- ascorbic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108608.7A GB202108608D0 (en) | 2021-06-16 | 2021-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
| EP22734289.6A EP4355368A1 (en) | 2021-06-16 | 2022-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
| CN202280043073.1A CN117500525A (zh) | 2021-06-16 | 2022-06-16 | pH调节的抗坏血酸溶液的制备 |
| US18/569,177 US20240350683A1 (en) | 2021-06-16 | 2022-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
| PCT/EP2022/066481 WO2022263592A1 (en) | 2021-06-16 | 2022-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
| JP2023577510A JP2024523884A (ja) | 2021-06-16 | 2022-06-16 | pH調整されたアスコルビン酸溶液の調製 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108608.7A GB202108608D0 (en) | 2021-06-16 | 2021-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202108608D0 true GB202108608D0 (en) | 2021-07-28 |
Family
ID=76954449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2108608.7A Ceased GB202108608D0 (en) | 2021-06-16 | 2021-06-16 | Preparation of a ph-adjusted ascorbic acid solution |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240350683A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355368A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523884A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500525A (cg-RX-API-DMAC7.html) |
| GB (1) | GB202108608D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263592A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007042781A2 (en) | 2005-10-10 | 2007-04-19 | Ge Healthcare Limited | Automated method for preparing technetium complexes |
| WO2011097649A2 (en) | 2010-02-08 | 2011-08-11 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102458396B (zh) * | 2009-04-15 | 2017-05-10 | 兰休斯医疗成像公司 | 使用抗坏血酸稳定化放射性药物组合物 |
| GB201915206D0 (en) * | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
-
2021
- 2021-06-16 GB GBGB2108608.7A patent/GB202108608D0/en not_active Ceased
-
2022
- 2022-06-16 EP EP22734289.6A patent/EP4355368A1/en active Pending
- 2022-06-16 US US18/569,177 patent/US20240350683A1/en active Pending
- 2022-06-16 CN CN202280043073.1A patent/CN117500525A/zh active Pending
- 2022-06-16 WO PCT/EP2022/066481 patent/WO2022263592A1/en not_active Ceased
- 2022-06-16 JP JP2023577510A patent/JP2024523884A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007042781A2 (en) | 2005-10-10 | 2007-04-19 | Ge Healthcare Limited | Automated method for preparing technetium complexes |
| WO2011097649A2 (en) | 2010-02-08 | 2011-08-11 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022263592A1 (en) | 2022-12-22 |
| EP4355368A1 (en) | 2024-04-24 |
| JP2024523884A (ja) | 2024-07-02 |
| CN117500525A (zh) | 2024-02-02 |
| US20240350683A1 (en) | 2024-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202012352XA (en) | Triesters of cyclohexanetripropionic acid | |
| ZA202107709B (en) | Cell-free production of ribonucleic acid | |
| IL236860A0 (en) | Herbicidal preparations containing 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or its derivative and triazolopyrimidine sulfonamides | |
| IL236856B (en) | Herbicidal preparations containing 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or its derivative and glyphosate or glufosinate | |
| IL232978B (en) | Herbicidal composition containing 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or derivative thereof and fluroxypyr or derivatives thereof | |
| GB202108607D0 (en) | Preparation of a ph-adjusted ascorbic acid solution | |
| PH12015500122A1 (en) | Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone | |
| GB201901982D0 (en) | Emulation of electrophysiological signals derived by stimulation of a body | |
| GB2593902B (en) | Salt of a pharmaceutical compound | |
| IL260316A (en) | A novel liquid formulation of long-acting human growth hormone conjugate | |
| WO2012053849A3 (ko) | 제모용 조성물 | |
| MX361275B (es) | Formulacion de capsula de acido 5-aminosalicilico. | |
| EP2794904A4 (en) | AMPLIFICATION OF A SEQUENCE FROM A RIBONUCLEIC ACID | |
| PT3592148T (pt) | Utilização de ácido beta-ciclocítrico ou um seu sal para intensificar a tolerância de plantas a estresse devido a seca | |
| GB202301180D0 (en) | Salt of a pharmaceutical compound | |
| ZA202201939B (en) | Production of malic acid | |
| IL286692A (en) | Crystal form of acid addition salt of furopyrimidine compound | |
| GB202108612D0 (en) | Ascorbic acid vial | |
| HUE064779T2 (hu) | A tapentadol foszforsav sójának elnyújtott hatóanyag-leadást biztosító adagolási formája | |
| GB202308485D0 (en) | Preparation of a solution of polymer/nucleic acid complexes | |
| EP3965771A4 (en) | FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH AS METHENAMINE MANDELATE | |
| ZA202210103B (en) | Preparation of a confectionery | |
| IL234087A0 (en) | The composition of an ascorbic acid derivative and a method for its production, a solution of an ascorbic acid derivative and an external preparation for the skin | |
| EP4409048A4 (en) | PREPARATION OF ALKALINE SALT SOLUTIONS | |
| ZA202211102B (en) | A preparation method of a palbociclib intermediate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |